Table 1.
Drug | Effect on bone | Comments |
---|---|---|
(1) Insulin | Anabolic to bone | Increased risk of falls due to hypoglycemia. Increased fracture risk could be a confounding effect of long disease duration, poor glycemic control and chronic complications |
(2) Insulin secretagogues | Neutral | May increase risk of falls by causing hypoglycemia |
(3) Metformin | Neutral or slightly positive | – |
(4) Thiazolidinediones | Decrease BMD | Increase bone marrow adipogenesis and decrease osteoblastic differentiation |
(5) GLP-1 agonists | Neutral or favourable | – |
(6) Dipeptidyl peptidase 4 (DPP4) inhibitors | Neutral or favourable | – |
(7) SGLT2 inhibitors | Increased fracture risk | Data are mainly with canagliflozin |